tiprankstipranks
Trending News
More News >
Mobile-health Network Solutions Class A (MNDR)
NASDAQ:MNDR
US Market
Advertisement

Mobile-health Network Solutions Class A (MNDR) AI Stock Analysis

Compare
160 Followers

Top Page

MNDR

Mobile-health Network Solutions Class A

(NASDAQ:MNDR)

Rating:42Neutral
Price Target:
$1.00
▲(28.21% Upside)
The overall score for MNDR reflects significant financial performance challenges, particularly in profitability and cash flow management, despite strong revenue growth. Technical analysis indicates a bearish trend, with the stock trading below key moving averages. Valuation metrics are unfavorable, with a negative P/E ratio and no dividend yield. The combination of these factors suggests caution for potential investors.
Positive Factors
Revenue Growth
The substantial revenue growth indicates strong market demand and successful product adoption, which can drive long-term business expansion and stability.
Improved Gross Profit Margin
An improved gross profit margin suggests better cost management and pricing power, enhancing the company's ability to generate profits over time.
Low Debt-to-Equity Ratio
A low debt-to-equity ratio indicates financial prudence, reducing risk and providing flexibility to invest in growth opportunities.
Negative Factors
Profitability Challenges
Persistent profitability challenges could hinder long-term financial health and limit the company's ability to reinvest in its business.
Negative Cash Flow to Net Income Ratio
Negative cash flow to net income ratio highlights difficulties in converting revenue into cash, which can strain liquidity and operational flexibility.
Negative Return on Equity
Negative ROE reflects inefficiencies in generating returns on shareholder investments, potentially impacting investor confidence and future capital raising.

Mobile-health Network Solutions Class A (MNDR) vs. SPDR S&P 500 ETF (SPY)

Mobile-health Network Solutions Class A Business Overview & Revenue Model

Company DescriptionMobile-health Network Solutions, an investment holding company, provides telehealth solutions in Singapore. The company operates in two segments, Telemedicine and Other Services, and Sale of Medicine and Medical Devices. It offers MaNaDr platform, a 360-degree healthcare ecosystem, which connects users and service providers through the range of healthcare services and product offerings that can be accessed through the mobile application and website. The company also provides a range of primary healthcare services, including general medical consultations, treatment and management of acute and chronic conditions in adults and children, vaccinations, and health screenings for work permit applications, as well as pre-employment health screening, children's health services, geriatric care services, and minor surgical procedures. In addition, it offers healthcare and wellness-related products through its online e-commerce platform; wholesale distribution of pharmaceutical products to clinics; and MaNaCare, a platform that provides a range of corporate healthcare and wellness services, including GP, specialist and allied healthcare panel services, tele-consultation services, in-person clinics, on-site health screening, and online marketplace and forum, as well as wellness programs to corporate customers. Further, the company develops IT systems on mobile phone and web portals; operates pharmacies, clinics, and drug stores; and offers beauty and other personal care services, as well as other general medical and health services. The company was founded in 2009 and is headquartered in Singapore.
How the Company Makes MoneyMNDR generates revenue through a combination of subscription-based services, licensing fees, and strategic partnerships. The company's primary revenue stream comes from healthcare providers subscribing to its telemedicine and remote monitoring platforms. These subscriptions typically involve recurring monthly or annual fees. Additionally, MNDR licenses its data analytics tools to hospitals and clinics, providing them with insights that inform patient care decisions. Strategic partnerships with healthcare organizations and technology companies also contribute to MNDR's earnings, enabling the company to expand its market reach and integrate its solutions into broader healthcare ecosystems.

Mobile-health Network Solutions Class A Financial Statement Overview

Summary
Mobile-health Network Solutions shows impressive revenue growth but struggles with profitability and cash flow management. The balance sheet is stable with a low debt-to-equity ratio, yet negative net income affects key metrics. Improvement in operational efficiencies and cash conversion is needed.
Income Statement
45
Neutral
Over the past year, Mobile-health Network Solutions demonstrated significant revenue growth of 142% and a considerable improvement in gross profit margin, moving from a negative to 18.17%. However, the company is still grappling with profitability issues, as evidenced by negative EBIT and net profit margins. These financial strains highlight a need for improved operational efficiencies and cost management.
Balance Sheet
50
Neutral
The company's balance sheet reveals a reasonable debt-to-equity ratio of 0.09, reflecting a conservative leverage approach. However, the return on equity (ROE) is negative due to consistent net losses, and the equity ratio stands at 52%, indicating moderate stability. The positive shift in stockholders' equity suggests efforts to strengthen the financial foundation, yet profitability remains a concern.
Cash Flow
40
Negative
Cash flow analysis shows challenges, with the operating cash flow to net income ratio negative, indicating cash flow management issues. Despite a substantial increase in free cash flow from the previous year, the free cash flow to net income ratio remains negative. This suggests ongoing difficulties in transforming revenue into cash, necessitating improved cash management strategies.
BreakdownJun 2024Jun 2023Jun 2022Jun 2021
Income Statement
Total Revenue13.97M5.77M5.14M1.92M
Gross Profit2.54M-1.02M594.99K-200.45K
EBITDA-15.55M-3.19M206.45K-597.73K
Net Income-15.60M-2.35M68.16K-460.15K
Balance Sheet
Total Assets7.95M2.54M7.73M693.92K
Cash, Cash Equivalents and Short-Term Investments6.77M1.64M7.36M121.39K
Total Debt376.01K292.45K42.48K60.79K
Total Liabilities3.81M2.82M1.67M5.18M
Stockholders Equity4.14M-271.32K6.06M-4.48M
Cash Flow
Free Cash Flow-6.54M-1.78M706.25K
Operating Cash Flow-6.41M-1.65M717.44K-475.05K
Investing Cash Flow-134.21K-136.29K-11.19K
Financing Cash Flow10.88M-4.25M6.79M387.59K

Mobile-health Network Solutions Class A Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.78
Price Trends
50DMA
1.01
Negative
100DMA
1.17
Negative
200DMA
1.82
Negative
Market Momentum
MACD
-0.07
Positive
RSI
35.62
Neutral
STOCH
19.85
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MNDR, the sentiment is Negative. The current price of 0.78 is below the 20-day moving average (MA) of 0.97, below the 50-day MA of 1.01, and below the 200-day MA of 1.82, indicating a bearish trend. The MACD of -0.07 indicates Positive momentum. The RSI at 35.62 is Neutral, neither overbought nor oversold. The STOCH value of 19.85 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for MNDR.

Mobile-health Network Solutions Class A Risk Analysis

Mobile-health Network Solutions Class A disclosed 70 risk factors in its most recent earnings report. Mobile-health Network Solutions Class A reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Mobile-health Network Solutions Class A Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
55
Neutral
$6.69B3.93-15.92%6.10%10.91%7.18%
54
Neutral
$153.56M12.68-5.98%-41.31%-163.08%
52
Neutral
$15.62M11.72-9.49%26.61%-156.30%
48
Neutral
$296.41M-535.24%17.53%14.49%
46
Neutral
$62.34M-138.17%4.20%-54.16%
42
Neutral
$1.81M-376.93%
40
Underperform
$4.02M-951.52%-0.70%-2.38%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
MNDR
Mobile-health Network Solutions Class A
0.78
-5.48
-87.54%
AMS
American Shared Hospital Services
2.49
-0.55
-18.09%
MODVQ
ModivCare
0.27
-12.45
-97.88%
TOI
Oncology Institute
3.05
2.75
916.67%
DCGO
DocGo
1.53
-2.11
-57.97%
PIII
P3 Health Partners
8.60
-16.34
-65.52%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 31, 2025